Increasing the performance of pooled CRISPR–Cas9 drop-out screening
Components of the type II CRISPR–Cas complex in bacteria have been used successfully in eukaryotic cells to facilitate rapid and accurate cell line engineering, animal model generation and functional genomic screens. Such developments are providing new opportunities for drug target identification an...
        Saved in:
      
    
          | Published in | Scientific reports Vol. 6; no. 1; p. 31782 | 
|---|---|
| Main Authors | , , , , , , , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        London
          Nature Publishing Group UK
    
        22.08.2016
     Nature Publishing Group  | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 2045-2322 2045-2322  | 
| DOI | 10.1038/srep31782 | 
Cover
| Abstract | Components of the type II CRISPR–Cas complex in bacteria have been used successfully in eukaryotic cells to facilitate rapid and accurate cell line engineering, animal model generation and functional genomic screens. Such developments are providing new opportunities for drug target identification and validation, particularly with the application of pooled genetic screening. As CRISPR–Cas is a relatively new genetic screening tool, it is important to assess its functionality in a number of different cell lines and to analyse potential improvements that might increase the sensitivity of a given screen. To examine critical aspects of screening quality, we constructed ultra-complex libraries containing sgRNA sequences targeting a collection of essential genes. We examined the performance of screening in both haploid and hypotriploid cell lines, using two alternative guide design algorithms and two tracrRNA variants in a time-resolved analysis. Our data indicate that a simple adaptation of the tracrRNA substantially improves the robustness of guide loss during a screen. This modification minimises the requirement for high numbers of sgRNAs targeting each gene, increasing hit scoring and creating a powerful new platform for successful screening. | 
    
|---|---|
| AbstractList | Components of the type II CRISPR–Cas complex in bacteria have been used successfully in eukaryotic cells to facilitate rapid and accurate cell line engineering, animal model generation and functional genomic screens. Such developments are providing new opportunities for drug target identification and validation, particularly with the application of pooled genetic screening. As CRISPR–Cas is a relatively new genetic screening tool, it is important to assess its functionality in a number of different cell lines and to analyse potential improvements that might increase the sensitivity of a given screen. To examine critical aspects of screening quality, we constructed ultra-complex libraries containing sgRNA sequences targeting a collection of essential genes. We examined the performance of screening in both haploid and hypotriploid cell lines, using two alternative guide design algorithms and two tracrRNA variants in a time-resolved analysis. Our data indicate that a simple adaptation of the tracrRNA substantially improves the robustness of guide loss during a screen. This modification minimises the requirement for high numbers of sgRNAs targeting each gene, increasing hit scoring and creating a powerful new platform for successful screening. | 
    
| ArticleNumber | 31782 | 
    
| Author | Riccombeni, Alessandro McCarthy, Nicola J. Hunt, Jessica R. Moore, Jonathan D. Lawo, Steffen Archer, Caroline R. Yarker, Joanne L. Little, Annette S. Cross, Benedict C. S.  | 
    
| Author_xml | – sequence: 1 givenname: Benedict C. S. surname: Cross fullname: Cross, Benedict C. S. email: Benedict.Cross@horizondiscovery.com organization: Horizon Discovery, 8100 Cambridge Research Park – sequence: 2 givenname: Steffen surname: Lawo fullname: Lawo, Steffen organization: Horizon Discovery, 8100 Cambridge Research Park – sequence: 3 givenname: Caroline R. surname: Archer fullname: Archer, Caroline R. organization: Horizon Discovery, 8100 Cambridge Research Park, Present address: AstraZeneca, The Darwin Building, Milton Rd, Milton, Cambridge CB4 0FZ, United Kingdom – sequence: 4 givenname: Jessica R. surname: Hunt fullname: Hunt, Jessica R. organization: Horizon Discovery, 8100 Cambridge Research Park, Present address: CRUK MedImmune Alliance Lab, Portway Building, Cambridge CB21 6GS, United Kingdom – sequence: 5 givenname: Joanne L. surname: Yarker fullname: Yarker, Joanne L. organization: Horizon Discovery, 8100 Cambridge Research Park – sequence: 6 givenname: Alessandro surname: Riccombeni fullname: Riccombeni, Alessandro organization: Horizon Discovery, 8100 Cambridge Research Park, Present address: DNAnexus, 1975 W El Camino Real #101, Mountain View, CA 94040, United States – sequence: 7 givenname: Annette S. surname: Little fullname: Little, Annette S. organization: Horizon Discovery, 8100 Cambridge Research Park – sequence: 8 givenname: Nicola J. surname: McCarthy fullname: McCarthy, Nicola J. organization: Horizon Discovery, 8100 Cambridge Research Park – sequence: 9 givenname: Jonathan D. surname: Moore fullname: Moore, Jonathan D. organization: Horizon Discovery, 8100 Cambridge Research Park  | 
    
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27545104$$D View this record in MEDLINE/PubMed | 
    
| BookMark | eNp9kc1KxDAUhYMo_i98AelShWpuktpkI8gw6oCg-LMOaSYdK52kJq3iznfwDX0SM8w4jiJmcwP3O-fenGygZeusQWgH8CFgyo-CNw2FnJMltE4wy1JCCVleuK-h7RAecTwZEQzEKlojecYywGwd9QdWe6NCZUdJ-2CSxvjS-bGy2iSuTBrnajNMejeD2-ubj7f3ngoiGXrXpK5rkxClxkbpFlopVR3M9qxuovuz_l3vIr28Oh_0Ti9TzQC3aV7kqiCizDnLhCacF0AAEwWgdaxYCABQ6niouGCGl1wDpyVQjWken1rQTXQw9e1so15fVF3Lxldj5V8lYDmJQ87jiPDJFG66YmyG2tjWq2-BU5X82bHVgxy5Z8mEIFxMDPZmBt49dSa0clwFbepaWeO6IIEDPSZAKIvo7uKs-ZCvoCOwPwW0dyHuWP67-NEvVletais3WbOq_1TMcgnR1Y6Ml4-u8zZ-xR_wJ27CrVE | 
    
| CitedBy_id | crossref_primary_10_1126_scitranslmed_abh1486 crossref_primary_10_1002_mc_23560 crossref_primary_10_1038_s41467_024_47987_x crossref_primary_10_1177_2472555219883621 crossref_primary_10_1016_j_isci_2025_111884 crossref_primary_10_1038_s41419_021_04191_9 crossref_primary_10_1038_s41598_019_46952_9 crossref_primary_10_1371_journal_pbio_3002767 crossref_primary_10_3389_fonc_2022_852980 crossref_primary_10_1038_s41598_017_18172_6 crossref_primary_10_15252_msb_202211267 crossref_primary_10_1038_s41598_017_07827_z crossref_primary_10_1093_nar_gkab309 crossref_primary_10_1038_s42255_021_00386_8 crossref_primary_10_1073_pnas_2316447121 crossref_primary_10_1038_s41467_018_07901_8 crossref_primary_10_1002_2211_5463_13482 crossref_primary_10_1016_j_ebiom_2020_103039 crossref_primary_10_1016_j_ccell_2021_06_018 crossref_primary_10_1016_j_molcel_2017_09_017 crossref_primary_10_1016_j_ymeth_2017_03_008 crossref_primary_10_1016_j_jmb_2018_06_034 crossref_primary_10_1089_crispr_2019_0066  | 
    
| Cites_doi | 10.1016/j.cell.2015.11.015 10.1038/nrg3899 10.1101/gr.177220.114 10.1016/j.cell.2013.12.001 10.1186/s13059-014-0554-4 10.1126/science.1247005 10.1126/science.1225829 10.1186/s13059-015-0843-6 10.1126/science.1246981 10.1038/nrmicro1793 10.1016/B978-0-12-801185-0.00016-7 10.1038/nature10886 10.1016/j.drudis.2014.12.016 10.1038/nmeth.3047 10.1126/science.1258096 10.1101/033068 10.1038/nbt.3536  | 
    
| ContentType | Journal Article | 
    
| Copyright | The Author(s) 2016 Copyright © 2016, The Author(s) 2016 The Author(s)  | 
    
| Copyright_xml | – notice: The Author(s) 2016 – notice: Copyright © 2016, The Author(s) 2016 The Author(s)  | 
    
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ADTOC UNPAY  | 
    
| DOI | 10.1038/srep31782 | 
    
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall  | 
    
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic  | 
    
| DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic  | 
    
| Database_xml | – sequence: 1 dbid: C6C name: SpringerLink Open Access Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository  | 
    
| DeliveryMethod | fulltext_linktorsrc | 
    
| Discipline | Biology | 
    
| EISSN | 2045-2322 | 
    
| EndPage | 31782 | 
    
| ExternalDocumentID | 10.1038/srep31782 PMC4992892 27545104 10_1038_srep31782  | 
    
| Genre | Journal Article | 
    
| GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS EJD ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT PJZUB PPXIY PQGLB PUEGO CGR CUY CVF ECM EIF NPM 7X8 5PM ADTOC AFFHD IPNFZ RIG UNPAY  | 
    
| ID | FETCH-LOGICAL-c410t-7b7ab29f78459c288b12102a11cc102099111aa6da894e8f8c183f13c037038b3 | 
    
| IEDL.DBID | M48 | 
    
| ISSN | 2045-2322 | 
    
| IngestDate | Wed Oct 29 11:34:25 EDT 2025 Tue Sep 30 16:26:36 EDT 2025 Fri Sep 05 06:21:46 EDT 2025 Mon Jul 21 05:33:49 EDT 2025 Wed Oct 01 02:20:00 EDT 2025 Thu Apr 24 23:11:25 EDT 2025 Fri Feb 21 02:38:26 EST 2025  | 
    
| IsDoiOpenAccess | true | 
    
| IsOpenAccess | true | 
    
| IsPeerReviewed | true | 
    
| IsScholarly | true | 
    
| Issue | 1 | 
    
| Language | English | 
    
| License | This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0 cc-by  | 
    
| LinkModel | DirectLink | 
    
| MergedId | FETCHMERGED-LOGICAL-c410t-7b7ab29f78459c288b12102a11cc102099111aa6da894e8f8c183f13c037038b3 | 
    
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present address: AstraZeneca, The Darwin Building, Milton Rd, Milton, Cambridge CB4 0FZ, United Kingdom. Present address: DNAnexus, 1975 W El Camino Real #101, Mountain View, CA 94040, United States. Present address: CRUK MedImmune Alliance Lab, Portway Building, Cambridge CB21 6GS, United Kingdom.  | 
    
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/srep31782 | 
    
| PMID | 27545104 | 
    
| PQID | 1813621234 | 
    
| PQPubID | 23479 | 
    
| PageCount | 1 | 
    
| ParticipantIDs | unpaywall_primary_10_1038_srep31782 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4992892 proquest_miscellaneous_1813621234 pubmed_primary_27545104 crossref_primary_10_1038_srep31782 crossref_citationtrail_10_1038_srep31782 springer_journals_10_1038_srep31782  | 
    
| ProviderPackageCode | CITATION AAYXX  | 
    
| PublicationCentury | 2000 | 
    
| PublicationDate | 20160822 2016-08-22 2016-Aug-22  | 
    
| PublicationDateYYYYMMDD | 2016-08-22 | 
    
| PublicationDate_xml | – month: 8 year: 2016 text: 20160822 day: 22  | 
    
| PublicationDecade | 2010 | 
    
| PublicationPlace | London | 
    
| PublicationPlace_xml | – name: London – name: England  | 
    
| PublicationTitle | Scientific reports | 
    
| PublicationTitleAbbrev | Sci Rep | 
    
| PublicationTitleAlternate | Sci Rep | 
    
| PublicationYear | 2016 | 
    
| Publisher | Nature Publishing Group UK Nature Publishing Group  | 
    
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group  | 
    
| References | Sanjana, Shalem, Zhang (CR10) 2014; 11 Shalem (CR13) 2014; 343 Li (CR6) 2015; 16 CR5 Essletzbichler (CR15) 2014; 24 Hart (CR16) 2015; 163 Chen, Huang (CR12) 2014; 546 CR17 CR9 Doudna, Charpentier (CR4) 2014; 346 Chen (CR14) 2013; 155 Jinek (CR18) 2012; 337 Wang, Wei, Sabatini, Lander (CR11) 2014; 343 Shalem, Sanjana, Zhang (CR3) 2015; 16 Wiedenheft, Sternberg, Doudna (CR2) 2012; 482 Sorek, Kunin, Hugenholtz (CR1) 2008; 6 Li (CR8) 2014; 15 Moore (CR7) 2015; 20 NE Sanjana (BFsrep31782_CR10) 2014; 11 B Chen (BFsrep31782_CR14) 2013; 155 T Wang (BFsrep31782_CR11) 2014; 343 BFsrep31782_CR9 R Sorek (BFsrep31782_CR1) 2008; 6 W Li (BFsrep31782_CR8) 2014; 15 P Essletzbichler (BFsrep31782_CR15) 2014; 24 B Wiedenheft (BFsrep31782_CR2) 2012; 482 T Hart (BFsrep31782_CR16) 2015; 163 BFsrep31782_CR17 W Li (BFsrep31782_CR6) 2015; 16 JD Moore (BFsrep31782_CR7) 2015; 20 O Shalem (BFsrep31782_CR13) 2014; 343 BFsrep31782_CR5 JA Doudna (BFsrep31782_CR4) 2014; 346 M Jinek (BFsrep31782_CR18) 2012; 337 O Shalem (BFsrep31782_CR3) 2015; 16 B Chen (BFsrep31782_CR12) 2014; 546  | 
    
| References_xml | – volume: 163 start-page: 1515 year: 2015 end-page: 1526 ident: CR16 article-title: High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities publication-title: Cell doi: 10.1016/j.cell.2015.11.015 – volume: 16 start-page: 299 year: 2015 end-page: 311 ident: CR3 article-title: High-throughput functional genomics using CRISPR–Cas9 publication-title: Nat. Rev. Genet. doi: 10.1038/nrg3899 – volume: 24 start-page: 2059 year: 2014 end-page: 2065 ident: CR15 article-title: Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line publication-title: Genome Res. doi: 10.1101/gr.177220.114 – volume: 155 start-page: 1479 year: 2013 end-page: 1491 ident: CR14 article-title: Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system publication-title: Cell doi: 10.1016/j.cell.2013.12.001 – volume: 15 start-page: 554 year: 2014 ident: CR8 article-title: MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens publication-title: Genome Biol. doi: 10.1186/s13059-014-0554-4 – volume: 343 start-page: 84 year: 2014 end-page: 87 ident: CR13 article-title: Genome-Scale CRISPR–Cas9 Knockout Screening in Human Cells publication-title: Science doi: 10.1126/science.1247005 – volume: 337 start-page: 816 year: 2012 end-page: 822 ident: CR18 article-title: A Programmable Dual-RNA – Guided DNA Endonuclease in Adaptice Bacterial Immunity publication-title: Science doi: 10.1126/science.1225829 – volume: 16 start-page: 281 year: 2015 ident: CR6 article-title: Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR publication-title: Genome Biol. doi: 10.1186/s13059-015-0843-6 – volume: 343 start-page: 80 year: 2014 end-page: 84 ident: CR11 article-title: Genetic screens in human cells using the CRISPR–Cas9 system publication-title: Science doi: 10.1126/science.1246981 – ident: CR17 – volume: 6 start-page: 181 year: 2008 end-page: 186 ident: CR1 article-title: CRISPR--a widespread system that provides acquired resistance against phages in bacteria and archaea publication-title: Nat. Rev. Microbiol. doi: 10.1038/nrmicro1793 – volume: 546 start-page: 337 year: 2014 end-page: 354 ident: CR12 article-title: Imaging genomic elements in living cells using CRISPR/Cas9 publication-title: Methods Enzymol. doi: 10.1016/B978-0-12-801185-0.00016-7 – ident: CR9 – volume: 482 start-page: 331 year: 2012 end-page: 338 ident: CR2 article-title: RNA-guided genetic silencing systems in bacteria and archaea publication-title: Nature doi: 10.1038/nature10886 – volume: 20 start-page: 450 year: 2015 end-page: 457 ident: CR7 article-title: The impact of CRISPR–Cas9 on target identification and validation publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2014.12.016 – ident: CR5 – volume: 11 start-page: 783 year: 2014 end-page: 784 ident: CR10 article-title: Improved vectors and genome-wide libraries for CRISPR screening publication-title: Nat. Methods doi: 10.1038/nmeth.3047 – volume: 346 start-page: 1258096 year: 2014 end-page: 1258096 ident: CR4 article-title: The new frontier of genome engineering with CRISPR–Cas9 publication-title: Science (80) doi: 10.1126/science.1258096 – volume: 346 start-page: 1258096 year: 2014 ident: BFsrep31782_CR4 publication-title: Science (80) doi: 10.1126/science.1258096 – volume: 343 start-page: 84 year: 2014 ident: BFsrep31782_CR13 publication-title: Science doi: 10.1126/science.1247005 – ident: BFsrep31782_CR9 doi: 10.1101/033068 – volume: 16 start-page: 281 year: 2015 ident: BFsrep31782_CR6 publication-title: Genome Biol. doi: 10.1186/s13059-015-0843-6 – volume: 337 start-page: 816 year: 2012 ident: BFsrep31782_CR18 publication-title: Science doi: 10.1126/science.1225829 – volume: 6 start-page: 181 year: 2008 ident: BFsrep31782_CR1 publication-title: Nat. Rev. Microbiol. doi: 10.1038/nrmicro1793 – volume: 343 start-page: 80 year: 2014 ident: BFsrep31782_CR11 publication-title: Science doi: 10.1126/science.1246981 – volume: 16 start-page: 299 year: 2015 ident: BFsrep31782_CR3 publication-title: Nat. Rev. Genet. doi: 10.1038/nrg3899 – volume: 15 start-page: 554 year: 2014 ident: BFsrep31782_CR8 publication-title: Genome Biol. doi: 10.1186/s13059-014-0554-4 – volume: 546 start-page: 337 year: 2014 ident: BFsrep31782_CR12 publication-title: Methods Enzymol. doi: 10.1016/B978-0-12-801185-0.00016-7 – volume: 24 start-page: 2059 year: 2014 ident: BFsrep31782_CR15 publication-title: Genome Res. doi: 10.1101/gr.177220.114 – volume: 482 start-page: 331 year: 2012 ident: BFsrep31782_CR2 publication-title: Nature doi: 10.1038/nature10886 – ident: BFsrep31782_CR5 doi: 10.1038/nbt.3536 – ident: BFsrep31782_CR17 – volume: 20 start-page: 450 year: 2015 ident: BFsrep31782_CR7 publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2014.12.016 – volume: 11 start-page: 783 year: 2014 ident: BFsrep31782_CR10 publication-title: Nat. Methods doi: 10.1038/nmeth.3047 – volume: 155 start-page: 1479 year: 2013 ident: BFsrep31782_CR14 publication-title: Cell doi: 10.1016/j.cell.2013.12.001 – volume: 163 start-page: 1515 year: 2015 ident: BFsrep31782_CR16 publication-title: Cell doi: 10.1016/j.cell.2015.11.015  | 
    
| SSID | ssj0000529419 | 
    
| Score | 2.313479 | 
    
| Snippet | Components of the type II CRISPR–Cas complex in bacteria have been used successfully in eukaryotic cells to facilitate rapid and accurate cell line... Components of the type II CRISPR-Cas complex in bacteria have been used successfully in eukaryotic cells to facilitate rapid and accurate cell line...  | 
    
| SourceID | unpaywall pubmedcentral proquest pubmed crossref springer  | 
    
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher  | 
    
| StartPage | 31782 | 
    
| SubjectTerms | 38/47 38/77 49/23 631/154/555 631/1647/2163 631/208/191 631/208/69 631/67/68 Base Sequence Cell Line, Tumor CRISPR-Cas Systems Gene Editing - methods Gene Targeting - methods Genetic Engineering - methods Genetic Testing - methods HEK293 Cells HL-60 Cells Humanities and Social Sciences Humans multidisciplinary Reproducibility of Results RNA, Guide, CRISPR-Cas Systems - genetics Science Science (multidisciplinary)  | 
    
| SummonAdditionalLinks | – databaseName: HAS SpringerNature Open Access 2022 dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bS8MwFD6MDVEfxLvzRnQ--FLsJWvSxzE25kCRzcHeSpKlKIy27ILszf_gP_SXeNq11TEFn_rQJG1ycnK-k5N8B-CmLjzBHVcaVNgOOijaMaTLpKE5o8p0PUulWUseHt3OgHaH9WEJavldmJX4fUrdjZYiRiPHcZ2tcJyPvAyVRqPb7xZbKUmwilpezhvk8Luizqq1WYOQ6ychi3DoNmzOw1gs3sR4_MPitHdhJ4OKpLGU7R6UdLgPG8vkkYsDaKFqJyfKsR2CKI7E31cASBSQJHeWHpFm777_1Pt8_2iKqUdGkyg2ovmM4GKBDixWPYRBu_Xc7BhZUgRDUcucGUwyIW0vYJzWPWVzLlMKMGFZSuETAR-uXkK4I8E9qnnAFSptYDnKdFC5uXSOoBxGoT4BgkIytS0kcyWjmkmPIhwQnNeDkUIUZVbhNh88X2WM4UniirGfRq4d7hfjXIXromi8pMn4rdBVLgEfJ3ESmRChjuZTH2EGGlI0orQKx0uJFM3YDEEeOo1VYCuyKgokBNmrb8LXl5QoG7059Cfxu7Vcqn6modPf_q5WCPzvPpz-q60z2EJg5SZ7z7Z9DuXZZK4vELzM5GU2eb8Avg_uCg priority: 102 providerName: Springer Nature – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9swDCa6FMPQQx_rtqboBq3ZoRenfsiWfAyCFG2BBUG2ANnJkGQZHRbYRmJjyE79D_uH-yWln13WDOjJB1O2JErkR4j6CPDJFb7gjicNKmwHAxTtGNJj0tCcUWV6vqXKqiWfx971jN7O3Xl9WX1Vp1VWlJalmW6ywy7RX6To6jiGgWH0AnY9F6F3B3Zn48ngW1FADqGJgejAbtiDHP7YZtPnPAGST_Mh20PRPXiVx6lY_xSLxV9-5-oAxk2Pq3STH_08k3316x8yx2cP6RD2awRKBpXAEezo-DW8rGpSro9hhBajSFTHjhEEhyR9vFlAkogUJbl0SIbTmy-T6Z_730Ox8km4TFIjyTOCNgjjYmz6BmZXo6_Da6OutWAoapmZwSQT0vYjxqnrK5tzWTKLCctSCp-II9EoCuGFgvtU84grtAWR5SjTQZvBpfMWOnES6xMgqHtT20IyTzKqmfQpogzBuRuFCsGZ2YWLRhuBqonIi3oYi6A8EHd40M5MF85b0bRi39gm9LFRaYB7ozjwELFO8lWA6AX9M_pm2oV3lYrbz9gMsSPGol1gG8pvBQre7c038fe7kn8bg0QMU_G_vWaZBPXGX23rXa9dQf8fw-mzpM6gky1z_R5hUCY_1Iv_AdyKDXg priority: 102 providerName: Unpaywall  | 
    
| Title | Increasing the performance of pooled CRISPR–Cas9 drop-out screening | 
    
| URI | https://link.springer.com/article/10.1038/srep31782 https://www.ncbi.nlm.nih.gov/pubmed/27545104 https://www.proquest.com/docview/1813621234 https://pubmed.ncbi.nlm.nih.gov/PMC4992892 https://www.nature.com/articles/srep31782.pdf  | 
    
| UnpaywallVersion | publishedVersion | 
    
| Volume | 6 | 
    
| hasFullText | 1 | 
    
| inHoldings | 1 | 
    
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVFSB databaseName: Free Full-Text Journals in Chemistry customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: HH5 dateStart: 20110101 isFulltext: true titleUrlDefault: http://abc-chemistry.org/ providerName: ABC ChemistRy – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: KQ8 dateStart: 20110101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: Directory of Open Access Journals (DOAJ) customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: ABDBF dateStart: 20121221 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: DIK dateStart: 20110101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD : Directory of Open Access Scholarly Resources customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M~E dateStart: 20110101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: RPM dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVAQT databaseName: Springer Nature - nature.com Journals - Fully Open Access customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: NAO dateStart: 20111201 isFulltext: true titleUrlDefault: https://www.nature.com/siteindex/index.html providerName: Nature Publishing – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2045-2322 dateEnd: 20191231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: 7X7 dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 2045-2322 dateEnd: 20191231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: BENPR dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2045-2322 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M48 dateStart: 20110801 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: HAS SpringerNature Open Access 2022 customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: AAJSJ dateStart: 20111201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Open Access Journals customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: C6C dateStart: 20111201 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature  | 
    
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwEB4tu0IsB8R7y6MyLAcugcRxY_uAUIm6WiptVXWpVE6R7ToCqUpCH4Le-A_8Q34J47zYaovEKVL8SOyxZ77xYz6AVz0llQgj7TFFQ3RQbOjpiGvPCs6MH8nAlKwlF6PofMqGs97sABqOzboDV3tdO8cnNV0u3vz4tn2PE_5ddWVcvEVbUqAZFKiJj9BAScfgcFGj_CrEN5WspPhwsdc9xBC0iTF0tfSuZboGN6-fmmy3Tm_DrU1WqO13tVhcsU5nd-FODStJvxoH9-DAZvfhZkU0uX0AA1QD7vQ51kMQ8ZHi73UBkqfE8WzZOYknHy_Hk98_f8VqJcl8mRdevlkTVCzo7GLRhzA9G3yKz72aQMEzLPDXHtdcaSpTLlhPGiqELsOFqSAwBp8IDlHTKRXNlZDMilQYnOBpEBo_REUgdPgIDrM8sydAUKC-pUrzSHNmuZYMoYMSopfODSIuvwOvm85LTB1d3JFcLJJylzsUSdvPHXjZZi2qkBr7Mr1oJJDggHe7GCqz-WaVICRBo4sGl3XgcSWRthrKERCig9kBviOrNoMLpr2bkn39UgbVRs8PfU_87mkj1aQZjPv-7rQV-L_b8OR_GvoUjhGDRW6ZmtJncLhebuxzxDlr3YUbfMa7cNTvDy-H-PwwGI0n-DaO4m65dtAtxzmmTEfj_uc_SQMDvg | 
    
| linkProvider | Scholars Portal | 
    
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3JTsMwEB1VIFQ4IHbKaigHLhFZ3Ng5oqhV2SoErdRbZLuOQKqSqItQb_wDf8iXMEmbQFWQOOUQe5J4Mp43HvsNwEVNeII7rjSosB0MULRjSJdJQ3NGlel6lsqqljy03GaH3nZr3RJU87Mwc_n7jLobPUWCTo7jPLuMAuyUIN93_WIhJU1VUcvLWYMcflX0mPc1CwBycR9kkQxdg_I4SsTkTfT7P_xNYwPWZ0CRXE81uwklHW3ByrR05GQb6mjY6X5ylEMQw5Hk-wAAiUOSVs7SPeI_3Tw_Pn2-f_hi6JHeIE6MeDwiOFVg-Ipdd6DTqLf9pjEriWAoapkjg0kmpO2FjNOap2zOZUYAJixLKbwi3MO5Swi3J7hHNQ-5QpMNLUeZDpo2l84uLEVxpPeBoIpMbQvJXMmoZtKjCAYE57WwpxBDmRW4zAcvUDO-8LRsRT_I8tYOD4pxrsB50TSZkmT81ugs10CAv3CalxCRjsfDAEEGulF0obQCe1ONFGJshhAPQ8YKsDldFQ1Seuz5O9HrS0aTjbEcRpP43Gqu1WBmn8Pf3q5aKPzvbzj4l6xTKDfbD_fB_U3r7hBWEWK56Sq0bR_B0mgw1scIY0byJPuNvwAKDu-V | 
    
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1fT9swED9tIAZ7mNjGn24DzNgDL9GS2Imdx6pr1RaGUDukvkW242hIVRLRVog3vgPfkE-yy9-uKpP2lIfYF8fn8_3Od74D-ObJQArqK4tJl6KBYqilfK4sIzjTth84uqha8vPK79-w4cSbVJfVZ1VYZZnSstim6-iw76gvMlR1As3AKH4Nm4JTHxfxZrs9HA-bQ5XcbcWcoM4gRMWy36reWQOT6zGRjWP0LWwvkkw-3Mvp9C_d09uFdxVoJO1ymO_hlUk-wFZZRvLhI3RRyPPYcqRDEM-RbHkZgKQxyatomYh0RoPx9ej58akjZwGJ7tLMShdzgtsGmrLYdQ9uet1fnb5VlUewNHPsucUVl8oNYi6YF2hXCFUkA5OOozU-EfrhPialH0kRMCNioVF8Y4dqm6KYC0X3YSNJE3MIBNllG1cq7ivODFcBQ2AghfDiSCOesltwXk9eqKvc4XkJi2lY-LCpCJt5bsHXpmlWJsx4qdFpzYEQl3Puo5CJSRezEAEHqlRUp6wFByVHGjIuR7iH5mML-AqvmgZ5quzVN8nt7yJlNtp1aFnid89qroaVrM5eGt1Zw_B__8On_6J1Am-uf_TCy8HVxWfYQbTl5wfSrvsFNuZ3C3OEiGaujqt1_AcGHPZ8 | 
    
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9swDCa6FMPQQx_rtqboBq3ZoRenfsiWfAyCFG2BBUG2ANnJkGQZHRbYRmJjyE79D_uH-yWln13WDOjJB1O2JErkR4j6CPDJFb7gjicNKmwHAxTtGNJj0tCcUWV6vqXKqiWfx971jN7O3Xl9WX1Vp1VWlJalmW6ywy7RX6To6jiGgWH0AnY9F6F3B3Zn48ngW1FADqGJgejAbtiDHP7YZtPnPAGST_Mh20PRPXiVx6lY_xSLxV9-5-oAxk2Pq3STH_08k3316x8yx2cP6RD2awRKBpXAEezo-DW8rGpSro9hhBajSFTHjhEEhyR9vFlAkogUJbl0SIbTmy-T6Z_730Ox8km4TFIjyTOCNgjjYmz6BmZXo6_Da6OutWAoapmZwSQT0vYjxqnrK5tzWTKLCctSCp-II9EoCuGFgvtU84grtAWR5SjTQZvBpfMWOnES6xMgqHtT20IyTzKqmfQpogzBuRuFCsGZ2YWLRhuBqonIi3oYi6A8EHd40M5MF85b0bRi39gm9LFRaYB7ozjwELFO8lWA6AX9M_pm2oV3lYrbz9gMsSPGol1gG8pvBQre7c038fe7kn8bg0QMU_G_vWaZBPXGX23rXa9dQf8fw-mzpM6gky1z_R5hUCY_1Iv_AdyKDXg | 
    
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increasing+the+performance+of+pooled+CRISPR%E2%80%93Cas9+drop-out+screening&rft.jtitle=Scientific+reports&rft.au=Cross%2C+Benedict+C.+S.&rft.au=Lawo%2C+Steffen&rft.au=Archer%2C+Caroline+R.&rft.au=Hunt%2C+Jessica+R.&rft.date=2016-08-22&rft.issn=2045-2322&rft.eissn=2045-2322&rft.volume=6&rft.issue=1&rft_id=info:doi/10.1038%2Fsrep31782&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_srep31782 | 
    
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon | 
    
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon | 
    
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |